Cantitate/Preț
Produs
Total produse
Vezi coșul
Novel Biomarkers in the Continuum of Breast Cancer de Vered Stearns

Novel Biomarkers in the Continuum of Breast Cancer: Advances in Experimental Medicine and Biology, cartea 882

Editat de Vered Stearns
en Limba Engleză Hardback – 29 mar 2016
This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today’s standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research.Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment(s) for individual patients.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 70386 lei  6-8 săpt.
  Springer International Publishing – 19 apr 2018 70386 lei  6-8 săpt.
Hardback (1) 71067 lei  6-8 săpt.
  Springer International Publishing – 29 mar 2016 71067 lei  6-8 săpt.

Din seria Advances in Experimental Medicine and Biology

  • 60% Clinical, Biological and Molecular Aspects of COVID-19
    Preț: 31629 lei
  • 5% Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health
    Preț: 109503 lei
  • 20% Metallomics: The Science of Biometals
    Preț: 69193 lei
  • 5% Pulmonary Function
    Preț: 70494 lei
  • 5% Pulmonary Infection and Inflammation
    Preț: 70494 lei
  • 5% Advances in Respiratory Cancerogenesis
    Preț: 70332 lei
  • 5% Respiratory Medicine and Science
    Preț: 70422 lei
  • 5% Current Concepts in Medical Research and Practice
    Preț: 23986 lei
  • Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders
    Preț: 64295 lei
  • 5% Advances in Microbiology, Infectious Diseases and Public Health: Volume 16
    Preț: 82042 lei
  • 5% Advancements in Clinical Research
    Preț: 70367 lei
  • 15% Pathophysiology of Respiration
    Preț: 62945 lei
  • 15% Noncommunicable Diseases
    Preț: 63060 lei
  • 5% Allergy and Respiration
    Preț: 101360 lei
  • 5% Respiratory Treatment and Prevention
    Preț: 70422 lei
  • 5% Respiratory Contagion
    Preț: 70514 lei
  • 20% Translational Informatics in Smart Healthcare
    Preț: 114210 lei
  • 5% Personalised Medicine: Lessons from Neurodegeneration to Cancer
    Preț: 115076 lei
  • 18% Substance and Non-substance Addiction
    Preț: 110097 lei
  • 5% Immune Metabolism in Health and Tumor
    Preț: 126672 lei
  • 5% Ambient Air Pollution and Health Impact in China
    Preț: 114501 lei
  • 5% Infectious Agents Associated Cancers: Epidemiology and Molecular Biology
    Preț: 108316 lei
  • 18% Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control
    Preț: 110469 lei
  • 5% Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine
    Preț: 141139 lei
  • 20% Healthcare and Big Data Management
    Preț: 102646 lei
  • 18% Transgenic Ascidians
    Preț: 93042 lei
  • 5% Chromosome Translocation
    Preț: 29257 lei
  • 18% Zic family: Evolution, Development and Disease
    Preț: 94147 lei
  • 18% Cellular and Molecular Toxicology of Nanoparticles
    Preț: 121488 lei
  • 5% Recombinant Antibodies for Infectious Diseases
    Preț: 121077 lei
  • 5% The Hair Fibre: Proteins, Structure and Development
    Preț: 127049 lei
  • 5% Obesity, Fatty Liver and Liver Cancer
    Preț: 108351 lei
  • 18% Biomimetic Medical Materials: From Nanotechnology to 3D Bioprinting
    Preț: 111370 lei
  • 5% Single Cell Biomedicine
    Preț: 114552 lei
  • 5% Arterial Chemoreceptors: New Directions and Translational Perspectives
    Preț: 139453 lei
  • 5% Drosophila Models for Human Diseases
    Preț: 128360 lei
  • 18% Novel Biomaterials for Regenerative Medicine
    Preț: 139377 lei
  • 18% Cutting-Edge Enabling Technologies for Regenerative Medicine
    Preț: 138912 lei
  • 24% Synthetic Biology of Cyanobacteria
    Preț: 80615 lei
  • 18% Survival Strategies in Extreme Cold and Desiccation: Adaptation Mechanisms and Their Applications
    Preț: 122229 lei
  • 5% Biostatistics for Human Genetic Epidemiology
    Preț: 140529 lei
  • 5% Atlas of Inherited Retinal Diseases
    Preț: 159134 lei
  • 5% Circular RNAs: Biogenesis and Functions
    Preț: 128309 lei
  • 18% Intelligent Orthopaedics: Artificial Intelligence and Smart Image-guided Technology for Orthopaedics
    Preț: 110593 lei
  • 5% Biological Mechanisms of Minimal Residual Disease and Systemic Cancer
    Preț: 107903 lei
  • 15% Integrative Structural Biology with Hybrid Methods
    Preț: 63891 lei
  • 5% Targeted Therapy of Colorectal Cancer Subtypes
    Preț: 107903 lei
  • 18% Biomedical Visualisation: Volume 1
    Preț: 92984 lei

Preț: 71067 lei

Preț vechi: 74807 lei
-5% Nou

Puncte Express: 1066
Preț estimativ în valută:
13600€ • 14169$ • 11308£

Carte tipărită la comandă

Livrare economică 10-24 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319229089
ISBN-10: 3319229087
Pagini: 281
Ilustrații: XIX, 279 p. 34 illus., 4 illus. in color.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.59 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Seriile Advances in Experimental Medicine and Biology, Breast Cancer Research Foundation

Locul publicării:Cham, Switzerland

Public țintă

Research

Cuprins

1 Genomic Biomarkers for Cancer Risk.- 2 Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.- 3 Incorporating Biomarkers in Studies of Chemoprevention.- 4 Breast Molecular Profiling and Radiotherapy Considerations.- 5 Prognostic and Predictive Biomarkers of Endocrine Responsiveness For Estrogen Receptor Positive Breast Cancer.- 6 Biomarkers for predicting response to Anti-HER2 Agents.- 7 Intratumor Heterogeneity in Breast Cancer.- 8 Intratumor Heterogeneity in Breast Cancer.- 9 Pharmacogenetic Predictors of Response.- 10 Metabolomics in Breast Cancer: Current Status and Perspectives.- 11 Circulating Tumor Cells.- 12 Circulating Plasma Tumor DNA.

Notă biografică

Vered Stearns is a Professor of Oncology and the Co-Director of the Breast and Ovarian Cancer Program at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, where she also holds the Breast Cancer Research Chair in Oncology. Dr. Stearns is an expert in novel drug investigation—her long-term research goal is to improve current therapies by individualizing strategies for the treatment and prevention of breast cancer. Her main research includes utilization of biomarkers to predict response to standard regimens used to treat and prevent breast cancer and to introduce new treatments. While administering standard chemotherapy in the preoperative setting, Dr. Stearns examines molecular markers and functional imaging to assist in the early determination of sensitivity or resistance to different treatments. Dr. Stearns and colleagues from the Consortium On Breast Cancer Pharamcogenomics (COBRA) were the first to evaluate the role of genetic variants in candidate genes such as CYP2D6 in tamoxifen metabolism, safety, and efficacy. The work has been extended to evaluate the role of genetic variants in aromatase inhibitor-associated outcomes. Dr. Stearns, who received numerous grants and awards to fund her innovative research, was a recipient of early career awards, including a Clinical Research Training Grant from the American Cancer Society, and was one of the first five recipients of the prestigious Damon Runyon Clinical Investigator Award. Subsequently, she was the inaugural recipient of the American Society of Clinical Oncology’s Advanced Clinical Research Award. She is an Editorial Board Member of Clinical Cancer Research, Breast Cancer Research and Treatment, and ONCOLOGY. Dr. Stearns’ work has been presented in key national and international meetings. She has published more than 150 scientific publications, which have been cited extensively.

Textul de pe ultima copertă

This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to today’s standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research. Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment for individual patients.

Caracteristici

Explores the latest research on genetic and epigenetic biomarkers in breast cancer Discusses metabolic pathways in predicting treatment response in breast cancer Covers the implications of circulating tumor cells, circulating DNA, and tumor heterogeneity in breast cancer research and therapy Includes supplementary material: sn.pub/extras